Contravisory Investment Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.1M | Buy |
4,341
+140
| +3% | +$32.6K | 0.19% | 98 |
|
|
2026
Q1 | $1.03M | Sell |
4,201
-210
| -5% | -$48.9K | 0.21% | 83 |
|
|
2025
Q4 | $913K | Buy |
4,411
+4,329
| +5,279% | +$856K | 0.18% | 82 |
|
|
2025
Q3 | $15.2K | Buy |
82
+52
| +173% | +$8.91K | ﹤0.01% | 324 |
|
|
2025
Q2 | $4.58K | Buy |
30
+23
| +329% | +$3.54K | ﹤0.01% | 347 |
|
|
2025
Q1 | $1.16K | Hold |
7
| – | – | ﹤0.01% | 364 |
|
|
2024
Q4 | $1.01K | Buy |
+7
| New | +$1.08K | ﹤0.01% | 372 |
|
|
2023
Q2 | – | Sell |
-2,076
| Closed | -$322K | – | 338 |
|
|
2023
Q1 | $322K | Sell |
2,076
-145
| -7% | -$23.4K | 0.09% | 155 |
|
|
2022
Q4 | $392K | Buy |
2,221
+304
| +16% | +$52.5K | 0.11% | 125 |
|
|
2022
Q3 | $313K | Buy |
1,917
+116
| +6% | +$19.6K | 0.1% | 126 |
|
|
2022
Q2 | $320K | Buy |
+1,801
| New | +$321K | 0.1% | 134 |
|
|
2020
Q4 | – | Sell |
-3
| Closed | – | – | 262 |
|
|
2020
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 270 |
|
|
2020
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 290 |
|
|
2020
Q1 | $0 | Buy |
+3
| New | +$426 | ﹤0.01% | 306 |
|
|
2019
Q2 | – | Sell |
-16
| Closed | -$2K | – | 305 |
|
|
2019
Q1 | $2K | Hold |
16
| – | – | ﹤0.01% | 288 |
|
|
2018
Q4 | $2K | Hold |
16
| – | – | ﹤0.01% | 270 |
|
|
2018
Q3 | $2K | Sell |
16
-43,377
| -100% | -$5.76M | ﹤0.01% | 267 |
|
|
2018
Q2 | $5.26M | Sell |
43,393
-472
| -1% | -$58.9K | 1.92% | 17 |
|
|
2018
Q1 | $5.62M | Sell |
43,865
-1,791
| -4% | -$242K | 2.07% | 13 |
|
|
2017
Q4 | $6.38M | Sell |
45,656
-5,670
| -11% | -$790K | 2.31% | 9 |
|
|
2017
Q3 | $6.67M | Sell |
51,326
-3,055
| -6% | -$405K | 2.38% | 7 |
|
|
2017
Q2 | $7.19M | Sell |
54,381
-5,551
| -9% | -$708K | 2.59% | 4 |
|
|
2017
Q1 | $7.46M | Sell |
59,932
-9,685
| -14% | -$1.16M | 2.63% | 4 |
|
|
2016
Q4 | $8.02M | Sell |
69,617
-2,998
| -4% | -$346K | 2.73% | 8 |
|
|
2016
Q3 | $8.58M | Sell |
72,615
-3,730
| -5% | -$453K | 2.76% | 9 |
|
|
2016
Q2 | $9.26M | Sell |
76,345
-4,413
| -5% | -$501K | 2.84% | 8 |
|
|
2016
Q1 | $8.74M | Sell |
80,758
-4,790
| -6% | -$496K | 2.55% | 13 |
|
|
2015
Q4 | $8.79M | Sell |
85,548
-17,563
| -17% | -$1.77M | 2.34% | 14 |
|
|
2015
Q3 | $9.63M | Sell |
103,111
-456
| -0.4% | -$44.1K | 2.26% | 20 |
|
|
2015
Q2 | $10.1M | Sell |
103,567
-5,372
| -5% | -$538K | 2.2% | 25 |
|
|
2015
Q1 | $11M | Buy |
108,939
+983
| +0.9% | +$100K | 2.2% | 27 |
|
|
2014
Q4 | $11.3M | Buy |
+107,956
| New | +$11.4M | 2.28% | 28 |
|
|
2014
Q2 | – | Sell |
-60
| Closed | -$6K | – | 162 |
|
|
2014
Q1 | $6K | Hold |
60
| – | – | ﹤0.01% | 137 |
|
|
2013
Q4 | $5K | Hold |
60
| – | – | ﹤0.01% | 114 |
|
|
2013
Q3 | $5K | Hold |
60
| – | – | ﹤0.01% | 107 |
|
|
2013
Q2 | $5K | Buy |
+60
| New | +$5.09K | ﹤0.01% | 115 |
|
Other funds holding JNJ
Contravisory Investment Management's JNJ Position: Q2 2026 in Review
Contravisory Investment Management increased its Johnson & Johnson (JNJ) stake by 3.3% in Q2 2026, buying an estimated $32.6K and bringing the position to 4,341 shares worth $1.1M. The position accounts for 0.19% of the portfolio, ranked #98.
Contravisory Investment Management first reported a position in JNJ in Q2 2013 and has held it in 36 quarters since. The position peaked at $11.3M in Q4 2014. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Contravisory Investment Management held 4,341 shares of Johnson & Johnson worth $1.1M as of Q2 2026.
- Contravisory Investment Management bought 140 Johnson & Johnson shares in Q2 2026, an estimated $32.6K.
- Johnson & Johnson made up 0.19% of Contravisory Investment Management's portfolio in Q2 2026, its #98 holding.
- Contravisory Investment Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 36 quarters since.
- Contravisory Investment Management's Johnson & Johnson position peaked at $11.3M in Q4 2014.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.